SE462895B - Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen - Google Patents

Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen

Info

Publication number
SE462895B
SE462895B SE8503664A SE8503664A SE462895B SE 462895 B SE462895 B SE 462895B SE 8503664 A SE8503664 A SE 8503664A SE 8503664 A SE8503664 A SE 8503664A SE 462895 B SE462895 B SE 462895B
Authority
SE
Sweden
Prior art keywords
cholinergic
dressing
fatty acid
compress
skin
Prior art date
Application number
SE8503664A
Other languages
English (en)
Swedish (sv)
Other versions
SE8503664L (sv
SE8503664D0 (sv
Inventor
A Fisher
A Levy
M Y Spiegelstein
J Y Grunwald
M Kushnir
Original Assignee
Israel Inst Biolog Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Israel Inst Biolog Res filed Critical Israel Inst Biolog Res
Publication of SE8503664D0 publication Critical patent/SE8503664D0/xx
Publication of SE8503664L publication Critical patent/SE8503664L/xx
Publication of SE462895B publication Critical patent/SE462895B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8503664A 1984-08-14 1985-08-01 Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen SE462895B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL72684A IL72684A (en) 1984-08-14 1984-08-14 Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs

Publications (3)

Publication Number Publication Date
SE8503664D0 SE8503664D0 (sv) 1985-08-01
SE8503664L SE8503664L (sv) 1986-02-15
SE462895B true SE462895B (sv) 1990-09-17

Family

ID=11055266

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8503664A SE462895B (sv) 1984-08-14 1985-08-01 Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen

Country Status (12)

Country Link
US (1) US4788063A (fr)
JP (1) JPS61186317A (fr)
CA (1) CA1260829A (fr)
CH (1) CH667393A5 (fr)
DE (1) DE3528979A1 (fr)
DK (1) DK168585B1 (fr)
FR (1) FR2569112B1 (fr)
GB (1) GB2163347B (fr)
IL (1) IL72684A (fr)
IT (1) IT1221024B (fr)
NO (1) NO173486C (fr)
SE (1) SE462895B (fr)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4855290A (en) 1985-05-10 1989-08-08 State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research Derivatives of quinuclidine
US4666926A (en) * 1986-02-27 1987-05-19 Warner-Lambert Company Transdermal formulations
US4908027A (en) * 1986-09-12 1990-03-13 Alza Corporation Subsaturated transdermal therapeutic system having improved release characteristics
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US5994392A (en) 1988-02-26 1999-11-30 Neuromedica, Inc. Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US5075312A (en) * 1988-10-27 1991-12-24 Leitman Esther M Novel anti-micturition composition and method
US5075314A (en) * 1988-10-27 1991-12-24 Leitman Esther M Antimicturition composition and novel method
DE3843238C1 (fr) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
DE3843239C1 (fr) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
CA2012192A1 (fr) * 1989-03-28 1990-09-28 Munir A. Hussain Administration intranasale de physostigmine et d'arecoline
NZ237241A (en) * 1990-03-02 1993-11-25 Pharmetrix Corp Method for increasing the storage stability of physostigmine
WO1991015176A1 (fr) * 1990-04-06 1991-10-17 Pharmetrix Corporation Dispositif et procede d'administration amelioree de physostigmine
US5429582A (en) * 1991-06-14 1995-07-04 Williams; Jeffery A. Tumor treatment
US5931774A (en) * 1991-06-14 1999-08-03 Proxima Therapeutics, Inc. Inflatable devices for tumor treatment
GB9118028D0 (en) * 1991-08-21 1991-10-09 Secr Defence Brit Improved transdrmal formulations
TW224048B (fr) * 1992-03-30 1994-05-21 Hoechst Roussel Pharma
US5596007A (en) * 1992-05-18 1997-01-21 Pharmaco Behavioral Associates, Inc. Therapeutic method to alleviate the craving associated with cessation of tobacco with cotinine
US5643928A (en) * 1992-10-21 1997-07-01 Pharmaco Behavioral Associates, Inc. Human body weight management
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
US5869505A (en) * 1993-02-02 1999-02-09 Keenan; Robert M. Nicotine metabolites and nicotine dependence
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
US5573774A (en) * 1993-02-02 1996-11-12 Keenan; Robert M. Nicotine metabolites, nicotine dependence and human body weight
DE4313928C2 (de) * 1993-04-28 1996-09-19 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur kontrollierten Abgabe von Pilocarpin an die Haut, Verfahren zu seiner Herstellung und seine Verwendung
DE4342174C1 (de) * 1993-12-10 1995-05-11 Lohmann Therapie Syst Lts Transdermales therapeutisches System sowie ein Verfahren zur Herstellung eines transdermalen therapeutischen Systems zur kombinierten transdermalen Anwendung von Physostigmin und Scopolamin für die Prophylaxe und zur Vorbehandlung einer Vergiftung durch hochtoxische phosphororganische Nervengifte, insbesondere Soman und seine Verwendung
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5861431A (en) * 1995-06-07 1999-01-19 Iotek, Inc. Incontinence treatment
DE19533089C1 (de) * 1995-09-07 1997-05-22 Hexal Ag Tacrin-Pflaster
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US6290986B1 (en) 1996-10-24 2001-09-18 Pharmaceutical Applications Associates, Llc Method and composition for transdermal administration of pharmacologic agents
US6572880B2 (en) 1996-10-24 2003-06-03 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US6479074B2 (en) 1996-10-24 2002-11-12 Pharmaceutical Applications Associates Llc Methods and transdermal compositions for pain relief
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US6146656A (en) * 1998-01-22 2000-11-14 Nitto Denko Corporation Percutaneous absorption preparation
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
JP3987655B2 (ja) * 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
ES2248107T3 (es) 1999-08-31 2006-03-16 Incyte San Diego Incorporated Benciliden-tiazolidindionas y analogos y su utilizacion en el tratamiento de la diabetes.
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
AU2002252227A1 (en) 2001-03-07 2002-09-24 Maxia Pharmaceuticals, Inc. Heterocyclic derivatives for the treatment of cancer and other proliferative diseases
CA2473156A1 (fr) * 2001-03-08 2002-09-19 Incyte San Diego, Inc. Molecules activant un recepteur rxr
CA2340824A1 (fr) * 2001-03-14 2002-09-14 Ibm Canada Limited-Ibm Canada Limitee Methode et systeme pour l'analyse du comportement des applications
EP1423107B1 (fr) 2001-03-23 2012-05-09 Luitpold Pharmaceuticals, Inc. Conjugues d'agents pharmaceutiques et d'alcools gras
US8552054B2 (en) * 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
EP1421061A4 (fr) * 2001-08-17 2004-12-22 Incyte San Diego Inc Derives d'oxime pour le traitement de la dyslipidemie et de l'hypercholesterolemie
JPWO2003028723A1 (ja) * 2001-09-27 2005-01-13 埼玉第一製薬株式会社 縮合イミダゾピリジン誘導体を含む経皮吸収用医薬組成物
JP2005513026A (ja) * 2001-11-15 2005-05-12 インサイト サン ディエゴ インコーポレイテッド 高コレステロール血症、異脂肪血症および他の代謝障害；癌、および他の疾患を治療するｎ−置換複素環
WO2003059542A1 (fr) 2002-01-17 2003-07-24 Lts Lohmann Therapie-Systeme Ag Procede permettant de neutraliser ou de recycler des materiaux supports destines a des revetements de type films
US7196108B2 (en) * 2002-03-08 2007-03-27 Incyte San Diego Inc. Bicyclic heterocycles for the treatment of diabetes and other diseases
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
US20040087576A1 (en) * 2002-11-05 2004-05-06 Haracz John L. Antimnemonic therapy for hypermemory syndromes
US20050014767A1 (en) * 2003-01-29 2005-01-20 Magnus Pfahl Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases
MXPA05011242A (es) * 2003-04-18 2006-07-06 Incyte San Diego Inc Compuestos isocromanos sustituidos para el tratamiento de trastornos metabolicos, cancer y otras enfermedades.
DE10338174A1 (de) 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (fr) * 2004-06-01 2005-12-01 Axonyx, Inc. Dispositif d'administration transdermique pour le traitement des troubles cognitifs
EP1604686A1 (fr) * 2004-06-08 2005-12-14 Axonyx, Inc. Utilisation de la phenserine et d'un inhibiteur de la HMG CoA reductase pour retarder la progression de la maladie d'Alzheimer
WO2006053186A2 (fr) * 2004-11-10 2006-05-18 The Trustees Of Columbia University In The City Of New York Methode de traitement de troubles moteurs
JP2007308403A (ja) * 2006-05-17 2007-11-29 Kenji Yoshida 皮膚外用剤
US20070287727A1 (en) * 2006-06-08 2007-12-13 Jacob Hiller Anti-Nicotine Treatment
WO2009142968A2 (fr) * 2008-05-20 2009-11-26 Olema Pharmaceuticals, Inc. Sels de l'acide valproïque
US9732324B2 (en) 2008-10-23 2017-08-15 Cornell University Anti-viral method
HRP20240648T1 (hr) 2013-03-15 2024-08-02 Tonix Pharma Holdings Limited Eutektičke formulacije ciklobenzaprin hidroklorida i manitola
CN118267382A (zh) 2017-12-11 2024-07-02 通尼克斯制药控股有限公司 用于痴呆和神经变性病况中的激越、精神病和认知衰退的环苯扎林治疗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE521851A (fr) *
GB469526A (en) * 1936-10-02 1937-07-27 Earl Barger Putt Acetyl-salicylic acid composition
AR207805A1 (es) * 1975-02-06 1976-10-29 Alza Corp Substrato apropiado para formar apositos para la dispensacion continua de escopolamina base por via transdermica
NL7806048A (nl) * 1978-06-02 1979-12-04 Kali Chemie Pharma Gmbh Geneesmiddel met betere resorptie-eigenschappen en werkwijze voor de bereiding daarvan.
GB2051574B (en) * 1979-05-10 1984-01-18 Kyoto Pharma Ind Adjuvant for promoting absorption of pharmacologically active substances through the rectum
US4286592A (en) * 1980-02-04 1981-09-01 Alza Corporation Therapeutic system for administering drugs to the skin
NL8104929A (nl) * 1980-11-12 1982-06-01 Alza Corp Anticholinergische preparaten, alsmede de bereiding en de toepassing ervan.
GB2105990B (en) * 1981-08-27 1985-06-19 Nitto Electric Ind Co Adhesive skin patches
DE3204551A1 (de) * 1982-02-10 1983-08-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung einer pharmazeutischen zubereitung in form eines polyacrylat-films
JPS58172312A (ja) * 1982-04-02 1983-10-11 Toa Eiyou Kagaku Kogyo Kk ニフエジピン外用剤
EP0127426A1 (fr) * 1983-05-23 1984-12-05 Takeda Chemical Industries, Ltd. Compositions pharmaceutiques percutanées pour application externe
JPS59216825A (ja) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd 経皮吸収外用製剤
DK243084A (da) * 1983-05-26 1984-11-27 Takeda Chemical Industries Ltd Perkutane farmaceutiske praeparater til udvortes brug
JPS60199834A (ja) * 1984-03-23 1985-10-09 Takeda Chem Ind Ltd 経皮吸収外用製剤
US4568343A (en) * 1984-10-09 1986-02-04 Alza Corporation Skin permeation enhancer compositions

Also Published As

Publication number Publication date
US4788063A (en) 1988-11-29
GB8519530D0 (en) 1985-09-11
NO173486B (no) 1993-09-13
SE8503664L (sv) 1986-02-15
IT1221024B (it) 1990-06-21
CH667393A5 (de) 1988-10-14
FR2569112B1 (fr) 1988-10-07
DE3528979A1 (de) 1986-02-27
NO853195L (no) 1986-02-17
DK168585B1 (da) 1994-05-02
IT8521922A0 (it) 1985-08-12
JPS61186317A (ja) 1986-08-20
GB2163347A (en) 1986-02-26
DK354985D0 (da) 1985-08-05
NO173486C (no) 1993-12-22
SE8503664D0 (sv) 1985-08-01
GB2163347B (en) 1989-01-25
IL72684A0 (en) 1984-11-30
DK354985A (da) 1986-02-15
IL72684A (en) 1989-02-28
CA1260829A (fr) 1989-09-26
DE3528979C2 (fr) 1989-12-07
FR2569112A1 (fr) 1986-02-21

Similar Documents

Publication Publication Date Title
SE462895B (sv) Transdermal farmaceutisk komposition bestaaende av ett kolinergt eller antikolinergt medel och en laagmolekylaer fettsyra samt ett foerband eller en kompress innehaallande kompositionen
AU630088B2 (en) Deprenyl for systemic transdermal administration
US5593686A (en) Pharmaceutical compositions
Pert et al. Localization of the antinociceptive action of morphine in primate brain
AU709379B2 (en) Transdermal formulation
EP0315218B1 (fr) Composition pharmaceutique
AU2001295512B2 (en) Combination of a transdermal therapeutic system and an oral and/or parenteral preparation containing dopamine agonists for the treatment of dopaminergic disease states
EP0727208B1 (fr) Formulation transdermale d'un composé à activité muscarinique
CN111346073B (zh) 一种透皮给药的药物组合物及其制备方法和应用
US5605701A (en) Transdermal formulation
US10376474B2 (en) Fentanyl-containing patch for external use
KR20070059079A (ko) 경피 페로스피론 투여용 의약적 조성물
PL175077B1 (pl) Przezskórny układ terapeutyczny do leczenia jaskry oraz sposób otrzymywania przezskórnego układu terapeutycznego do leczenia jaskry
JPS62148422A (ja) 治療システム
JPH0648962A (ja) 経皮吸収製剤用組成物
WO2024037545A1 (fr) Composition transdermique de dexmédétomidine, patch transdermique et procédé de préparation de patch transdermique et son utilisation
JP6978417B2 (ja) プラミペキソール経皮送達系及びその使用
EP0315217A2 (fr) Composition pharmaceutique
MXPA97006143A (en) Transderm formulation

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8503664-8

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8503664-8

Format of ref document f/p: F